Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation Capacity

  • Adrián LLerena
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
  • Pedro Dorado
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
  • Eva M Peñas-Lledó
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.

収録刊行物

  • Pharmacogenomics

    Pharmacogenomics 10 (1), 17-28, 2008-12-23

    Informa UK Limited

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ